Skip to Main Content

Author Details

Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
1997
63
32
PMIDPaper TitleJournal TitlePublished Year
37339580Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.Blood2023
37884999The Quartet Data Portal: integration of community-wide resources for multiomics quality control.Genome Biol2023
37339580Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.Blood2023
37884999The Quartet Data Portal: integration of community-wide resources for multiomics quality control.Genome Biol2023
34996510Achieving robust somatic mutation detection with deep learning models derived from reference data sets of a cancer sample.Genome Biol2022
36352452Personalized genome assembly for accurate cancer somatic mutation discovery using tumor-normal paired reference samples.Genome Biol2022
36514120Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies.Genome Biol2022
34980216Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.Genome Biol2022
34996510Achieving robust somatic mutation detection with deep learning models derived from reference data sets of a cancer sample.Genome Biol2022
36514120Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies.Genome Biol2022
36352452Personalized genome assembly for accurate cancer somatic mutation discovery using tumor-normal paired reference samples.Genome Biol2022
34980216Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.Genome Biol2022
33349700A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples.Nat Biotechnol2021
33531477A multi-center cross-platform single-cell RNA sequencing reference dataset.Sci Data2021
33349700A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples.Nat Biotechnol2021
33184494A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma.Leukemia2021
34504347Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.Nat Biotechnol2021
34504346Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Nat Biotechnol2021
34949218Author Correction: The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
34872606The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
33531477A multi-center cross-platform single-cell RNA sequencing reference dataset.Sci Data2021
34949218Author Correction: The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
34872606The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
34504347Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.Nat Biotechnol2021
34504346Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Nat Biotechnol2021
33184494A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma.Leukemia2021
32299816A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models.Clin Cancer Res2020
32299816A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models.Clin Cancer Res2020
33139544Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma.Proc Natl Acad Sci U S A2020
33139544Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma.Proc Natl Acad Sci U S A2020
30941572Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.J Cancer Res Clin Oncol2019
31092200Correction to: Similarities and differences between variants called with human reference genome HG19 or HG38.BMC Bioinformatics2019
31510940dnAQET: a framework to compute a consolidated metric for benchmarking quality of de novo assemblies.BMC Genomics2019
31114935Sequencing XMET genes to promote genotype-guided risk assessment and precision medicine.Sci China Life Sci2019
31151983A novel model of controlling PD-L1 expression in ALK<sup>+</sup> anaplastic large cell lymphoma revealed by CRISPR screening.Blood2019
30941572Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.J Cancer Res Clin Oncol2019
31305208Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev2019
31510940dnAQET: a framework to compute a consolidated metric for benchmarking quality of de novo assemblies.BMC Genomics2019
31305208Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev2019
31151983A novel model of controlling PD-L1 expression in ALK<sup>+</sup> anaplastic large cell lymphoma revealed by CRISPR screening.Blood2019
31092200Correction to: Similarities and differences between variants called with human reference genome HG19 or HG38.BMC Bioinformatics2019
31114935Sequencing XMET genes to promote genotype-guided risk assessment and precision medicine.Sci China Life Sci2019
28634199Characterising <i>cis</i>-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.Gut2018
28634199Characterising <i>cis</i>-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.Gut2018
30112248Application of genome analysis strategies in the clinical testing for pediatric diseases.Pediatr Investig2018
30057145Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.Cancer Cell2018
30380422Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.Cell Rep2018
29603380Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma.Mol Carcinog2018
29641966Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.N Engl J Med2018
29067470Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans.Arch Toxicol2018
  • 1 - 50 of 126

Recommended Authors

Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 1
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year 2009
Number of shared co-authors 1
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 10
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 2
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 6
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
Ryan D Morin
Simon Fraser University
Career Start Year 2005
Number of shared co-authors 6
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 6
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 5
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 9
Jason Walker
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 0
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 2
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 6
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 2
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 4
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 9
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 1
Michael N Edmonson
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 4
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 8
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 7
Marco A Marra
University of British Columbia
Career Start Year 1993
Number of shared co-authors 8
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 10
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 5
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 9

Collaborators

Louis M Staudt
National Cancer Institute, National Institutes of Health
Co-authored papers 27
Huixiao Hong
Co-authored papers 15
Weida Tong
National Center for Toxicological Research
Co-authored papers 14
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 13
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers 11
Baitang Ning
Co-authored papers 10
Chunlin Xiao
Chongqing Aier Eye Hospital
Co-authored papers 7
Michele Ceribelli
National Center for Advancing Translational Sciences
Co-authored papers 7
Ming Shi
Co-authored papers 6
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Andreas Scherer
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 6
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Rebecca Kusko
Immuneering Corporation
Co-authored papers 5
Wei Wei
Co-authored papers 5
Charles Wang
Co-authored papers 5
Tieliu Shi
Co-authored papers 4
Jonathan Foox
Co-authored papers 4
Neset Cevdet Tolga Emre
Bogazici University
Co-authored papers 4
Joshua Xu
Co-authored papers 4
Ulrika Liljedahl
Co-authored papers 4
Jessica Nordlund
Uppsala University
Co-authored papers 4
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 3
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Co-authored papers 3
Gloria M Petersen
Mayo Clinic
Co-authored papers 3
Erich Jaeger
Illumina Inc.
Co-authored papers 3
Weigong Ge
Co-authored papers 3
Sayed Mohammad Ebrahim Sahraeian
Roche Sequencing Solutions Inc.
Co-authored papers 3
Rajarshi Guha
Vertex Pharmaceuticals
Co-authored papers 3
Gary P Schroth
Co-authored papers 3
Hong Fang
National Center for Toxicological Research (NCTR)
Co-authored papers 3
Release 1.2